In your mind what are the implications of the LEADER trial evaluating liraglutide in reducing CV outcomes?

In your mind what are the implications of the LEADER trial evaluating liraglutide in reducing CV outcomes?

In your mind what are the implications of the LEADER trial evaluating liraglutide in reducing CV outcomes?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Chantal Mathieu, MD, PhD

Chantal Mathieu, MD, PhD

Professor of Medicine
Program Director of Biomedical Sciences
Katholieke Universiteit
Chair of Endocrinology
University Hospital Gasthuisberg
Leuven, Belgium